They might therefore be helpful for COVID-19-positive diabetic patients, despite the fact that there is currently little information about the effectiveness of DPP4 inhibitors in treating hyperglycemia in COVID-19 patients [44]. This evidence concerns the gene DPP4 and COVID-19.